Use Able AI chat for product recommendations

TGF Beta Receptor I Polyclonal antibody

TGF beta Receptor I Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, ELISA

TGFβ RI, AAT5, Activin receptor like kinase 5, ACVRLK4, ALK 5, ALK5, LDS1A, LDS2A, SKR4, TbetaR I, TGF beta Receptor I, TGF beta receptor type 1, TGF beta receptor type I, TGF beta type I receptor, TGFBR1, TGFR 1

Formulation:  PBS, Azide, Glycerol
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for TGF beta Receptor I in ?

Product Information

55391-1-AP targets TGF beta Receptor I in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name transforming growth factor, beta receptor 1
Calculated Molecular Weight 56 kDa
Observed Molecular Weight 56 kDa
GenBank Accession NumberNM_004612
Gene Symbol TGFBR1
Gene ID (NCBI) 7046
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP36897
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Publications

What published studies show

TGF Beta Receptor I Polyclonal Antibody (55391-1-AP) – Citation Summary

This TGF Beta Receptor I polyclonal antibody (catalog #55391-1-AP) has a total of 5 citations across peer-reviewed journals:

  • EBioMedicine – hepatocellular carcinoma metastasis via TGF-β signaling
  • Oncogene – gastric cancer stemness and chemoresistance
  • J Cell Mol Med – peritoneal fibrosis and apoptosis (peritoneal dialysis)
  • Exp Parasitol – hepatic fibrosis in Schistosoma japonicum infection (mouse)
  • CNS Neurosci Ther – glioblastoma cell growth suppression and SMAD signaling (2026)

Research fields covered include oncology (liver, gastric, brain cancer), fibrosis, cellular signaling (TGF-β/SMAD), and apoptosis. Applications validated include WB and IHC in human and mouse samples.

SpeciesApplicationTitle
humanWB,IHC

EBioMedicine

POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.

Authors - Boshi Wang
humanWB

Oncogene

MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.

Authors - Wanming He
humanWB

J Cell Mol Med

Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.

Authors - Jingjing Wu
mouseWB

Exp Parasitol

Lentivirus-mediated over-expression of let-7b microRNA suppresses hepatic fibrosis in the mouse infected with Schistosoma japonicum.

Authors - Na Tang

CNS Neurosci Ther

Tumor Treating Fields Enhance Temozolomide-Associated Growth Suppression in Glioblastoma Cells and Patient-Derived Organoids Through Cell-Cycle Blockade, Apoptosis, and SMAD-Associated Signaling.

Authors - Haiping Zhu
Loading...
||
New chat

Able®

正在加载,请稍候...